San Carlos, CA, United States of America

Jiaxin Yu

This inventor holds 67 USPTO granted patents and 14 published patent applications, plus 11 CIPO patents and 25 EPO patents, primarily in Kinase Inhibitors (CPC class C07D). Top assignees: Rigel Pharmaceuticals, Incorporated, Curasen Therapeutics, Inc., Bristol-Myers Squibb Compnay. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiaxin Yu. Retrieved from https://idiyas.com/inventor/jiaxin-yu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 67 (Patent Applications = 14)

% Patents Active = 80.6

CIPO Patents = 11 (Patent Applications = 5)

EPO Patents = 25 (Patent Applications = 23)

Average Co-Inventor Count = 6.3

ph-index = 9

Forward Citations = 281(Granted Patents)

Forward Citations (Not Self Cited) = 124(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Carlos, CA (US) (2010 - 2023)
Foster City, CA (US) (2013 - 2024)

Company Filing History:

62 out of 492

Rigel Pharmaceuticals, Incorporated

patents

3 out of 8

Curasen Therapeutics, Inc.

patents

2 out of 3,746

Bristol-Myers Squibb Compnay

patents

4. 1 out of 41

Bristol Meyers Squibb Company

patents

5. 1 out of 4,520

Eli Lilly and Company

patents

6. 1 out of 834,659

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

Beta Adrenergic Agonist

RIP1K Inhibitors

TGF-Beta Inhibitors

Tyrosine Kinase Inhibitors

Fumarate Analogs

Prodrugs

Heterocyclic Compounds

Pyrimidine Compounds

Substituted Triazoles

Axl Inhibitors

Carboxamide Compounds

AMPK-Activating Compounds

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448352 - Beta adrenergic agonist and methods of using the same (2025-10-21),

2. 12297202 - RIP1K inhibitors (2025-05-13),

3. 12227508 - TGF-β inhibitors (2025-02-18),

4. 11919890 - RIP1 inhibitory compounds and methods for making and using the same (2024-03-05),

5. 11672791 - Tyrosine kinase inhibitors (2023-06-13),

6. 11667643 - RIP1K inhibitors (2023-06-06),

7. 11578078 - Heterocyclic RIP1 inhibitory compounds (2023-02-14),

8. 11564930 - RIP1 inhibitory compounds and methods for making and using the same (2023-01-31),

9. 11524955 - 2,4-diamino-pyrimidine compounds and method for making and using the compounds (2022-12-13),

10. 11466018 - TGF-β inhibitors (2022-10-11),

11. 11407736 - RIP1 inhibitory compounds and methods for making and using the same (2022-08-09),

12. 11352360 - TGF-beta inhibitors (2022-06-07),

13. 11129819 - Fumarate analogs and uses thereof (2021-09-28),

14. 11110082 - Tyrosine kinase inhibitors (2021-09-07),

15. 11040944 - Beta adrenergic agonist and methods of using the same (2021-06-22),

Title: The Innovative Journey of Jiaxin Yu

Introduction: Jiaxin Yu, a talented inventor based in San Carlos, CA (US), has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Jiaxin Yu holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his career, Jiaxin Yu has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have the potential to revolutionize various industries.

Collaborations: Jiaxin Yu has collaborated with top scientists, engineers, and researchers from around the world, fostering a culture of innovation and knowledge sharing to drive forward progress in the field of technology.

Conclusion: Jiaxin Yu's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, makes him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology in remarkable ways.

Profile summary based on public USPTO records.